PPIL2
Basic information
Region (hg38): 22:21666000-21700015
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PPIL2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 29 | 30 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 29 | 1 | 1 |
Variants in PPIL2
This is a list of pathogenic ClinVar variants found in the PPIL2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-21666113-A-G | not specified | Uncertain significance (Nov 09, 2023) | ||
22-21671020-A-C | not specified | Uncertain significance (Oct 25, 2023) | ||
22-21671037-G-A | not specified | Uncertain significance (Jun 21, 2023) | ||
22-21672356-A-G | not specified | Uncertain significance (Jun 17, 2022) | ||
22-21675109-A-G | not specified | Uncertain significance (Feb 23, 2023) | ||
22-21681335-C-A | not specified | Uncertain significance (Jun 22, 2024) | ||
22-21681335-C-G | not specified | Uncertain significance (Aug 26, 2022) | ||
22-21681375-C-T | Benign (Mar 29, 2018) | |||
22-21681382-G-A | not specified | Uncertain significance (Apr 26, 2023) | ||
22-21682490-C-G | not specified | Uncertain significance (Jun 05, 2024) | ||
22-21682503-C-T | not specified | Uncertain significance (Dec 20, 2023) | ||
22-21683186-C-T | not specified | Uncertain significance (May 03, 2023) | ||
22-21683215-A-G | not specified | Uncertain significance (Dec 08, 2021) | ||
22-21683254-C-T | not specified | Uncertain significance (Jun 11, 2024) | ||
22-21684773-G-A | not specified | Uncertain significance (Jan 08, 2024) | ||
22-21684797-A-G | not specified | Uncertain significance (May 04, 2023) | ||
22-21684848-G-C | not specified | Uncertain significance (Feb 15, 2023) | ||
22-21686486-C-A | not specified | Uncertain significance (May 18, 2023) | ||
22-21686529-C-T | not specified | Uncertain significance (Jan 04, 2022) | ||
22-21686547-C-T | not specified | Uncertain significance (Dec 30, 2023) | ||
22-21686916-G-A | not specified | Uncertain significance (Jun 11, 2021) | ||
22-21686963-A-G | not specified | Uncertain significance (Oct 06, 2021) | ||
22-21687694-G-A | not specified | Uncertain significance (Mar 11, 2024) | ||
22-21687721-C-T | not specified | Uncertain significance (Jan 26, 2022) | ||
22-21687722-G-A | not specified | Uncertain significance (Nov 07, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PPIL2 | protein_coding | protein_coding | ENST00000412327 | 21 | 47746 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000823 | 0.999 | 125666 | 1 | 81 | 125748 | 0.000326 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.64 | 247 | 331 | 0.746 | 0.0000204 | 3487 |
Missense in Polyphen | 61 | 106.45 | 0.57304 | 1136 | ||
Synonymous | 0.171 | 130 | 133 | 0.981 | 0.00000908 | 960 |
Loss of Function | 3.65 | 12 | 35.5 | 0.338 | 0.00000169 | 404 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000123 | 0.000123 |
Ashkenazi Jewish | 0.00169 | 0.00169 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000212 | 0.000211 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00126 | 0.00121 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Has a ubiquitin-protein ligase activity acting as an E3 ubiquitin protein ligase or as an ubiquitin-ubiquitin ligase promoting elongation of ubiquitin chains on substrates. By mediating 'Lys-48'-linked polyubiquitination of proteins could target them for proteasomal degradation (PubMed:11435423). May also function as a chaperone, playing a role in transport to the cell membrane of BSG/Basigin for instance (PubMed:15946952). Probable inactive PPIase with no peptidyl-prolyl cis-trans isomerase activity (PubMed:20676357). {ECO:0000269|PubMed:11435423, ECO:0000269|PubMed:15946952, ECO:0000269|PubMed:20676357}.;
- Pathway
- Ubiquitin mediated proteolysis - Homo sapiens (human);Cell surface interactions at the vascular wall;Hemostasis;Basigin interactions
(Consensus)
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- loftool
- 0.875
- rvis_EVS
- -0.6
- rvis_percentile_EVS
- 18.19
Haploinsufficiency Scores
- pHI
- 0.241
- hipred
- Y
- hipred_score
- 0.625
- ghis
- 0.622
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 1.00
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ppil2
- Phenotype
Gene ontology
- Biological process
- protein polyubiquitination;protein peptidyl-prolyl isomerization;protein folding;leukocyte migration;protein localization to plasma membrane
- Cellular component
- nucleus;nucleoplasm;cytoplasm;Golgi lumen;plasma membrane
- Molecular function
- peptidyl-prolyl cis-trans isomerase activity;protein binding;cyclosporin A binding;ubiquitin-ubiquitin ligase activity;ubiquitin protein ligase activity